Robert Dickey - 31 Dec 2021 Form 5 Insider Report for AngioGenex, Inc. (AGGX)

Role
Director, INDEPENDENT DIRECTOR
Signature
/s/ ROBERT DICKEY IV
Issuer symbol
AGGX
Transactions as of
31 Dec 2021
Net transactions value
+$32,500
Form type
5
Filing time
16 Feb 2022, 12:49:31 UTC
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGGX Stock Option Award $32,500 +250,000 +42% $0.1300* 850,000 02 Sep 2021 Common Stock 250,000 $0.1300 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.